Top Markets
#1 Cross Cross +11.65%
#2 Gama Token Gama Token +9.13%
#3 Ontology Gas Ontology Gas +7.49%
#4 龙虾 (Lobster) 龙虾 (Lobster) +5.27%
#5 Humanity Humanity +4.70%
#6 Akedo Akedo +4.52%
#7 Pieverse Pieverse +4.13%
#8 Berachain Berachain +3.67%
#9 The Innovation Game The Innovation Game +3.22%
#10 Perle Perle +3.19%
Coin of the day
Cross Cross
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
Kedudukan dalam Saham #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Harga Saham
$5.34
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$2.59M
Perubahan (1 hari)
-11.00%
Perubahan (1 tahun)
313.95%
Negara
US
Perdagangan Jupiter Neurosciences, Inc. (JUNS)

Kategori

Healthcare
Hasil untuk Jupiter Neurosciences, Inc. (JUNS)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Jupiter Neurosciences, Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Jupiter Neurosciences, Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE